Lsl Pharma Group Inc(LSL-X)
TSX Venture

Today's Change
Delayed Last Update

Lsl Pharma Group Inc

540, rue d'Avaugour
Bureau 1800
Boucherville QC J4B 0G6 CAN
P: 450-664-7700
F: 450-857-1065
https://www.groupelslpharma.com

Sectors & Indices

Sector
Industry
Employees

Profile

LSL Pharma Group Inc develops, manufactures and commercializes sterile pharmaceutical products, cosmetic products and natural health products. It operates in three segments CMO activities include four operating entities LSL Laboratory, Dermolab, Du-Var, and VSI; Integrated Eye-care pharmaceutical company which includes sterile Eye-care manufacturing operation; and Private Label Business includes Juno OTC which commercializes pharmaceutical products with a focus on private label, over the counter (OTC) products. It derives majority of revenue from CMO activities segment.

Key Executives

NameTitle
Luc MainvilleCFO/Executive VP
Guy-Paul AllardSecretary/Vice President, Divisional
Francois RobergeCEO/Director/President

More from The Globe

Energy sector insiders are ramping up their bets against oil bears
Ted Dixon
Bullish potential on Intact Financial Corp.
Monica Rizk
top links
Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
Future headquarters of Ontario Power Generation, Oshawa, March 2025.
trade secrets
Where will tech stocks go from here?
Happy man investor. Crypto currency up trend. Growth chart concept. Trade Chart. Cryptocurrency mining, bitcoin exchange, blockchain and marketing technology, internet money flat vector illustration.
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored
Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
the mover
Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
number cruncher
Top U.S. stocks ranked by Trading Central’s quantitative model
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.